ONTX
Traws Pharma, Inc.$8.37 +0.86 (+11.45%)
Oct 27 4:00 PM ET · prev $7.51
Since first trade
−67.4%
from $25.64 · Jun 24
30 days
−47.8%
from $16.03
Range since listing
$7.18–35.38
−76% from high · low Oct 23
Avg volume 20D
26.7K
Oct 23 spike 245.0K
Short interest
16.0K
+180.3%
Days to cover
2.1
at average volume
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Jul 31 Short interest falls 77.8% to 844
- E Aug 7 Trading halt: Halt Resumed: ONTX — trading resumed after M (Volatility T…
- X Aug 14 Short interest falls 62.4% to 317
- X Aug 31 Short interest jumps 63.1% to 517
- E Sep 4 Trial readout: T-90d Trial Readout: TRX-100 (Phase 2)
- E Sep 8 Trial readout: T-90d Trial Readout: TRX-100 (Phase 2)
- X Sep 15 Short interest jumps 885.9% to 5.1K
- X Oct 15 Short interest jumps 180.3% to 16.0K
Signal stack
Where each data set points today.
- Short sellersBUILDING
Short interest +180.3% to 16.0K shares. 2.1 days to cover.
- TrendDOWNTREND
42% below its 50-day average. New closing low $7.18 on Oct 23.
Who's buying
13F| Top holder | Shares | Value |
|---|---|---|
| UBS Group AG | 127 | $4.5K |
Quarterly 13F filings are due 45 days after each quarter ends.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 8, 2026 Clinical trial readout
T-90d Trial Readout: TRX-100 (Phase 2)
Trial: This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Ma
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 8, 2026
Trial readout
T-90d Trial Readout: TRX-100 (Phase 2)
Trial: This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate…
Sep 6, 2026
Trial readout
T-90d Trial Readout: TRX-100 (Phase 2)
Trial: This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate…
Sep 4, 2026
Trial readout
T-90d Trial Readout: TRX-100 (Phase 2)
Trial: This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate…
Aug 7, 2026
Trading halt
Halt Resumed: ONTX — trading resumed after M (Volatility Trading Pause)
Halted 2026-08-07T13:30:56.000Z | Resumed 2026-08-07T13:35:56.000Z
Aug 7, 2026
Trading halt
Trading Halt: ONTX — M (Volatility Trading Pause)
Corgi ONTO 2x Daily ETF | Market: Non NASDAQ | Code: M — Volatility Trading Pause
Short side
FINRA· Oct 15, 202616,010
shares short
+180.3%
vs prior settlement
2.1
days to cover
Trading halts
| Aug 7, 2026 | Volatility Pause | Resumed |
| Jul 30, 2026 | Volatility Pause | Resumed |